Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,445 | 285 | 96.2% |
| Education | $254.32 | 5 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,141 | 51 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $1,045 | 39 | $0 (2024) |
| Alkermes, Inc. | $1,012 | 40 | $0 (2024) |
| ITI, Inc. | $911.73 | 36 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $755.71 | 31 | $0 (2024) |
| Indivior Inc. | $409.11 | 21 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $383.78 | 18 | $0 (2024) |
| Lundbeck LLC | $292.77 | 16 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $260.55 | 20 | $0 (2024) |
| ABBVIE INC. | $175.20 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,586 | 78 | Neurocrine Biosciences, Inc. ($315.64) |
| 2023 | $2,347 | 101 | Janssen Pharmaceuticals, Inc ($412.59) |
| 2022 | $1,205 | 55 | Janssen Pharmaceuticals, Inc ($246.79) |
| 2021 | $1,561 | 56 | ITI, Inc. ($427.18) |
All Payment Transactions
290 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $21.16 | General |
| 11/28/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $37.13 | General |
| Category: Neuroscience | ||||||
| 11/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: CNS | ||||||
| 11/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $30.95 | General |
| Category: Neuropsychiatry | ||||||
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $0.94 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $2.04 | General |
| Category: PSYCHIATRY | ||||||
| 11/01/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $32.70 | General |
| Category: Neuropsychiatry | ||||||
| 10/29/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $3.23 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: CNS | ||||||
| 10/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $3.41 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Neuroscience | ||||||
| 10/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Neuropsychiatry | ||||||
| 10/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: Neuropsychiatry | ||||||
| 10/04/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.46 | General |
| Category: PSYCHIATRY | ||||||
| 09/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $30.88 | General |
| Category: Neuropsychiatry | ||||||
| 09/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Neuropsychiatry | ||||||
| 09/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Neuropsychiatry | ||||||
| 09/09/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Neurology | ||||||
| 09/09/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $1.31 | General |
| Category: Neurology | ||||||
| 09/05/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Neuroscience | ||||||
| 09/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: PSYCHIATRY | ||||||
About Nadezhda Davis
Nadezhda Davis is a Psychiatric/Mental Health healthcare provider based in Lynwood, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1033269188.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nadezhda Davis has received a total of $6,699 in payments from pharmaceutical and medical device companies, with $1,586 received in 2024. These payments were reported across 290 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($6,445).
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Nurse Practitioner
- Location Lynwood, CA
- Active Since 01/11/2007
- Last Updated 09/22/2020
- Taxonomy Code 163WP0808X
- Entity Type Individual
- NPI Number 1033269188
Products in Payments
- CAPLYTA (Drug) $1,172
- INGREZZA (Drug) $1,045
- INVEGA SUSTENNA (Drug) $1,012
- ARISTADA (Drug) $476.75
- PERSERIS (Drug) $409.11
- REXULTI (Drug) $310.10
- AUSTEDO (Drug) $275.42
- ABILIFY MAINTENA (Drug) $269.98
- Vivitrol (Drug) $261.31
- VIVITROL (Drug) $250.83
- Austedo XR (Drug) $182.30
- VRAYLAR (Drug) $175.20
- UZEDY (Drug) $130.00
- HETLIOZ (Drug) $104.38
- INVEGA TRINZA (Drug) $99.42
- ABILIFY ASIMTUFII (Drug) $96.47
- Wakix (Drug) $68.82
- WAKIX (Drug) $65.18
- SPRAVATO (Drug) $29.41
- COBENFY (Drug) $27.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Lynwood
Joanne Blair-Randolph
Psychiatric/Mental Health — Payments: $4,315
Nakia Simon
Psychiatric/Mental Health — Payments: $2,257
Jorge Trujillo
Psychiatric/Mental Health — Payments: $972.79
Chris Vieira, Rn, RN
Psychiatric/Mental Health — Payments: $287.88
Charmane Henry-Daigle, Rn, RN
Psychiatric/Mental Health
Anna Bayya
Psychiatric/Mental Health